Stage FocusSeries A, Series B+
GeographyUS, China, Southeast Asia
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
LYFE Capital operates as a transpacific healthcare investment platform with $2B total AUM, anchored by the $935M Fund IV (2022). With 5 global offices including Menlo Park and Singapore, the fund invests across therapeutics/pharma, life science tools/diagnostics, and medtech. Across 43 companies over 11 years, they average 4 new investments annually with a track record of 20+ IPOs and 10+ M&As cov...
Notable Investments
B
Burning Rock BioP
Pliant TherapeuticsC
Cytek BiosciencesP
Profound BioSimilar Funds
Ally Bridge Group
New York, United States
DeepTech NativeBiotechMedTechSeries ASeries B+
Lilly Asia Ventures
Shanghai, China
DeepTech NativeBiotechMedTechSynthetic BiologySeries ASeries B+
Vivo Capital
Palo Alto, United States
DeepTech NativeBiotechMedTechSeedSeries A
5AM Ventures
Boston, United States
DeepTech NativeBiotechMedTechSeries ASeries B+
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Agent Capital
Waltham, United States
DeepTech NativeBiotechMedTechNeurotechSeedSeries A